Evaluating Hip Osteoarthritis as a Risk Factor for Immune Checkpoint Inhibitor–Induced Inflammatory Arthritis

CT-derived hip OA was not significantly associated with development of ICI-IA in this cohort of patients with lung cancer. ICI-IA was associated with decreased mortality.

Authors

Institutions

Publication Details

Journal
The Journal of Rheumatology
Published
2026-01-15
DOI
https://doi.org/10.3899/jrheum.2025-0808
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluating Hip Osteoarthritis as a Risk Factor for Immune Checkpoint Inhibitor–Induced Inflammatory Arthritis

Julie R. Brahmer, Laura C. Cappelli, Durrant Barasa, Joseph A. Murray et al.
The Journal of Rheumatology
Cancer Immunotherapy and Biomarkers
article

Evaluating Hip Osteoarthritis as a Risk Factor for Immune Checkpoint Inhibitor–Induced Inflammatory Arthritis

Julie R. Brahmer, Laura C. Cappelli, Durrant Barasa, Joseph A. Murray, Rebecca Fitzpatrick, Clifton O. Bingham, Elena Ghotbi, Ami A. Shah
article en

Abstract

CT-derived hip OA was not significantly associated with development of ICI-IA in this cohort of patients with lung cancer. ICI-IA was associated with decreased mortality.

The Journal of Rheumatology
Johns Hopkins University (US), Johns Hopkins Medicine (US)
Good health and well-being
Openalex Percentile: Top 87%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.